154 related articles for article (PubMed ID: 20009044)
1. Clinical effectiveness of implantable cardioverter-defibrillators among medicare beneficiaries with heart failure.
Hernandez AF; Fonarow GC; Hammill BG; Al-Khatib SM; Yancy CW; O'Connor CM; Schulman KA; Peterson ED; Curtis LH
Circ Heart Fail; 2010 Jan; 3(1):7-13. PubMed ID: 20009044
[TBL] [Abstract][Full Text] [Related]
2. Impact of age and medical comorbidity on the effectiveness of implantable cardioverter-defibrillators for primary prevention.
Chan PS; Nallamothu BK; Spertus JA; Masoudi FA; Bartone C; Kereiakes DJ; Chow T
Circ Cardiovasc Qual Outcomes; 2009 Jan; 2(1):16-24. PubMed ID: 20031808
[TBL] [Abstract][Full Text] [Related]
3. Biventricular implantable cardioverter defibrillators improve survival compared with biventricular pacing alone in patients with severe left ventricular dysfunction.
Ermis C; Lurie KG; Zhu AX; Collins J; Vanheel L; Sakaguchi S; Lu F; Pham S; Benditt DG
J Cardiovasc Electrophysiol; 2004 Aug; 15(8):862-6. PubMed ID: 15333075
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of implantable cardioverter defibrillators in patients >or=65 years of age.
Sanders GD; Kong MH; Al-Khatib SM; Peterson ED
Am Heart J; 2010 Jul; 160(1):122-31. PubMed ID: 20598982
[TBL] [Abstract][Full Text] [Related]
5. Quality of care and outcomes in women hospitalized for heart failure.
Klein L; Grau-Sepulveda MV; Bonow RO; Hernandez AF; Williams MV; Bhatt DL; Fonarow GC
Circ Heart Fail; 2011 Sep; 4(5):589-98. PubMed ID: 21862732
[TBL] [Abstract][Full Text] [Related]
6. Hospital variation and characteristics of implantable cardioverter-defibrillator use in patients with heart failure: data from the GWTG-HF (Get With The Guidelines-Heart Failure) registry.
Shah B; Hernandez AF; Liang L; Al-Khatib SM; Yancy CW; Fonarow GC; Peterson ED;
J Am Coll Cardiol; 2009 Feb; 53(5):416-22. PubMed ID: 19179199
[TBL] [Abstract][Full Text] [Related]
7. Temporal trends in patient characteristics and outcomes among Medicare beneficiaries undergoing primary prevention implantable cardioverter-defibrillator placement in the United States, 2006-2010. Results from the National Cardiovascular Data Registry's Implantable Cardioverter-Defibrillator Registry.
Borne RT; Peterson PN; Greenlee R; Heidenreich PA; Wang Y; Curtis JP; Tzou WS; Varosy PD; Kremers MS; Masoudi FA
Circulation; 2014 Sep; 130(10):845-53. PubMed ID: 25095884
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous use of implantable cardioverter-defibrillators and left ventricular assist devices in patients with severe heart failure.
Kühne M; Sakumura M; Reich SS; Sarrazin JF; Wells D; Chalfoun N; Crawford T; Boonyapisit W; Horwood L; Chugh A; Good E; Jongnarangsin K; Bogun F; Oral H; Morady F; Pagani F; Pelosi F
Am J Cardiol; 2010 Feb; 105(3):378-82. PubMed ID: 20102952
[TBL] [Abstract][Full Text] [Related]
9. Influence of a performance-improvement initiative on quality of care for patients hospitalized with heart failure: results of the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure (OPTIMIZE-HF).
Fonarow GC; Abraham WT; Albert NM; Gattis Stough W; Gheorghiade M; Greenberg BH; O'Connor CM; Pieper K; Sun JL; Yancy CW; Young JB;
Arch Intern Med; 2007 Jul; 167(14):1493-502. PubMed ID: 17646603
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: a meta-analysis of randomized controlled trials.
Ghanbari H; Dalloul G; Hasan R; Daccarett M; Saba S; David S; Machado C
Arch Intern Med; 2009 Sep; 169(16):1500-6. PubMed ID: 19752408
[TBL] [Abstract][Full Text] [Related]
11. [14-year experience with implantable cardioverter/defibrillators: determination of prognosis and discharge behavior].
Vester EG; Dees H; Dobran I; Hennersdorf M; Perings C; Heydthausen M; Winter J; Strauer BE
Z Kardiol; 2000; 89 Suppl 3():194-205. PubMed ID: 10810803
[TBL] [Abstract][Full Text] [Related]
12. Heart failure and the risk of shocks in patients with implantable cardioverter defibrillators: results from the Triggers Of Ventricular Arrhythmias (TOVA) study.
Whang W; Mittleman MA; Rich DQ; Wang PJ; Ruskin JN; Tofler GH; Muller JE; Albert CM;
Circulation; 2004 Mar; 109(11):1386-91. PubMed ID: 14993132
[TBL] [Abstract][Full Text] [Related]
13. Posttraumatic stress symptoms and predicted mortality in patients with implantable cardioverter-defibrillators: results from the prospective living with an implanted cardioverter-defibrillator study.
Ladwig KH; Baumert J; Marten-Mittag B; Kolb C; Zrenner B; Schmitt C
Arch Gen Psychiatry; 2008 Nov; 65(11):1324-30. PubMed ID: 18981344
[TBL] [Abstract][Full Text] [Related]
14. Heart rate predicts outcomes in an implantable cardioverter-defibrillator population.
Ahmadi-Kashani M; Kessler DJ; Day J; Bunch TJ; Stolen KQ; Brown S; Sbaity S; Olshansky B;
Circulation; 2009 Nov; 120(21):2040-5. PubMed ID: 19901194
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of defibrillator therapy or amiodarone in chronic stable heart failure: results from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT).
Mark DB; Nelson CL; Anstrom KJ; Al-Khatib SM; Tsiatis AA; Cowper PA; Clapp-Channing NE; Davidson-Ray L; Poole JE; Johnson G; Anderson J; Lee KL; Bardy GH;
Circulation; 2006 Jul; 114(2):135-42. PubMed ID: 16818817
[TBL] [Abstract][Full Text] [Related]
16. Implantable cardioverter-defibrillator efficacy in patients with heart failure and left ventricular dysfunction (from the MADIT II population).
Zareba W; Piotrowicz K; McNitt S; Moss AJ;
Am J Cardiol; 2005 Jun; 95(12):1487-91. PubMed ID: 15950580
[TBL] [Abstract][Full Text] [Related]
17. Association Between Comorbidities and Outcomes in Heart Failure Patients With and Without an Implantable Cardioverter-Defibrillator for Primary Prevention.
Khazanie P; Hellkamp AS; Fonarow GC; Bhatt DL; Masoudi FA; Anstrom KJ; Heidenreich PA; Yancy CW; Curtis LH; Hernandez AF; Peterson ED; Al-Khatib SM
J Am Heart Assoc; 2015 Aug; 4(8):e002061. PubMed ID: 26251283
[TBL] [Abstract][Full Text] [Related]
18. Quality of care and outcomes of older patients with heart failure hospitalized in the United States and Canada.
Ko DT; Tu JV; Masoudi FA; Wang Y; Havranek EP; Rathore SS; Newman AM; Donovan LR; Lee DS; Foody JM; Krumholz HM
Arch Intern Med; 2005 Nov; 165(21):2486-92. PubMed ID: 16314545
[TBL] [Abstract][Full Text] [Related]
19. Impact of implantable cardioverter defibrillators on survival and recurrent hospitalization in advanced heart failure.
Nazarian S; Maisel WH; Miles JS; Tsang S; Stevenson LW; Stevenson WG
Am Heart J; 2005 Nov; 150(5):955-60. PubMed ID: 16290971
[TBL] [Abstract][Full Text] [Related]
20. Predictors of in-hospital mortality in patients hospitalized for heart failure: insights from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF).
Abraham WT; Fonarow GC; Albert NM; Stough WG; Gheorghiade M; Greenberg BH; O'Connor CM; Sun JL; Yancy CW; Young JB;
J Am Coll Cardiol; 2008 Jul; 52(5):347-56. PubMed ID: 18652942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
